China Graves’ disease market is expected to grow at a CAGR of around 5.8% during the forecast period. Chinese Economy is growing considerably, and it has become a preferred destination for setting business due to cheap labor, improved infrastructure, and a large customer base. China’s market has both medium and long-term potential due to its large market size, aging population, fluctuating disease profile and rapidly improving life. The Chinese economy is becoming an R&D-intensive economy which is the major factor for the growth of the life science industry of China, and in turns affects China Graves’ disease market. Along with this, government support in the country is also affecting the growth of the market. The corporate tax rate in China is 16% as compared with other countries including India at around 35%. China has a large number of pharmaceutical and medical device companies as it is the manufacturing hub for pharmaceutical drugs base supplies.
To know more information, please request a free report sample https://www.omrglobal.com/request-sample/china-graves-disease-market
Further, the prevalence of diabetes in China is increasing at an alarming rate, owing to the increasing geriatric population in the country along with unhealthy dietary habits and lack of physical activity. According to IDF, China has the largest number of people suffering from diabetes. Moreover, there are over 46,900 children and adolescents suffering from type-1 diabetes, owing to the large population of individuals of this age group in the country. Such a high prevalence and incidence rate of diabetes in the country possesses a high risk for the development of Grave’s disease in the patients, thus influencing the China Graves’ disease market.
A full report of China Graves’ disease Market is available at: https://www.omrglobal.com/industry-reports/china-graves-disease-market
Further, the footprints of the key players such as Abbott Laboratories Inc., Allergan PLC, Eli Lilly and Co., GlaxoSmithKline PLC, Merck & Co. Inc., Mylan NV, Novartis International AG including other regional players are also driving the China Graves’ disease market. Besides, there were numerous activities done for the development of an improved method for the establishment of a model of Graves' disease in BALB/c mice, and various other research activities.
China Graves’ disease Market – Segmentation
• Imaging Tests
• Radioactive Iodine Uptake
• Blood Sample
• Anti- Thyroid Medication
• Radioactive Iodine Therapy
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/china-graves-disease-market
• Abbott Laboratories Inc.
• Allergan PLC
• Eli Lilly and Co.
• GlaxoSmithKline PLC
• Johnson & Johnson
• Macleods Pharmaceuticals Ltd.
• Merck & Co. Inc.
• Mylan NV
• Novartis International AG
• Pfizer Inc.
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com/
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404